clarithromycin has been researched along with malondialdehyde in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamis, T; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Laoutaris, G; Mouktaroudi, M; Perrea, D; Sabracos, L | 1 |
| Antonopoulou, A; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Koutoukas, P; Panagou, C; Perrea, D; Sabracos, L | 1 |
| Adamis, T; Baziaka, F; Giamarellos-Bourboulis, E; Giamarellou, H; Karayannacos, P; Koutoukas, P; Plachouras, D; Raftogiannis, M; Sabracos, L; Tsaganos, T | 1 |
| Adamis, T; Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Panagou, C; Raftogiannis, M; Tsaganos, T; Tziortzioti, V | 1 |
| Ergin, H; Özdemir, ÖM; Şimşek, NG; Türk, NŞ; Yenisey, Ç | 1 |
| Ding, H; Gao, M; Li, Q; Lu, J; Wang, H; Wang, Z; Zhong, G | 1 |
| Cağlayan Yeğen, B; Can, G; Deniz, M; Duman, DG; Ercan, F; Kumral, ZN | 1 |
| Bansal, S; Chhibber, S | 1 |
| Andersen, JT; Broedbaek, K; Cejvanovic, V; Hansen, LK; Henriksen, T; Jimenez-Solem, E; Kjaer, LK; Larsen, EL; Lykkesfeldt, J; Pedersen, MT; Petersen, M; Popik, SD; Poulsen, HE; Torp-Pedersen, C; Weimann, A | 1 |
| Guo, J; Kanerva, M; Lei, Y; Li, Q; Peng, J; Song, J; Sun, H | 1 |
2 trial(s) available for clarithromycin and malondialdehyde
| Article | Year |
|---|---|
The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Anti-Bacterial Agents; Body Fluids; Chronic Disease; Clarithromycin; Combined Modality Therapy; Diathermy; Humans; Male; Malondialdehyde; Nitric Oxide; Pelvic Pain; Prostatitis; Quality of Life; Radiofrequency Therapy; Semen; Sulfonamides; Superoxide Dismutase; Tamsulosin; Urination Disorders; Zinc | 2012 |
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Deoxyguanosine; DNA; Guanosine; Healthy Volunteers; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Penicillin V; Placebos; Reactive Oxygen Species; RNA; Trimethoprim; Young Adult | 2017 |
8 other study(ies) available for clarithromycin and malondialdehyde
| Article | Year |
|---|---|
Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Immunity; Lipopolysaccharides; Male; Malondialdehyde; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Sepsis; Survival Analysis; Tumor Necrosis Factor-alpha | 2004 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Lipopolysaccharides; Malondialdehyde; Pyelonephritis; Rabbits; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Topics: Acute Disease; Amikacin; Animals; Anti-Bacterial Agents; Caspase 3; Caspases; Clarithromycin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Immunologic Factors; Male; Malondialdehyde; Pulmonary Edema; Pyelonephritis; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Kidney; Lipopolysaccharides; Liver; Lung; Male; Malondialdehyde; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Spleen; Tumor Necrosis Factor-alpha | 2006 |
Protective effects of clarithromycin in rats with hypoxia/reoxygenation-induced intestinal injury.
Topics: Animals; Animals, Newborn; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Necrotizing; Glutathione; Ileum; Injections, Subcutaneous; Intestinal Mucosa; Lipid Peroxidation; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2010 |
Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antioxidants; Chemical and Drug Induced Liver Injury; Clarithromycin; Diarrhea; Gastrointestinal Transit; Glutathione; Ileum; Inflammation; Intestinal Diseases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methotrexate; Neutrophil Infiltration; Oxidative Stress; Peroxidase; Probiotics; Rats; Rats, Sprague-Dawley; Saccharomyces | 2013 |
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Curcumin; Disease Models, Animal; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Malondialdehyde; Mice, Inbred BALB C; Nitric Oxide; Peroxidase; Pneumonia; Tumor Necrosis Factor-alpha | 2014 |
Comparison of oxidative stress induced by clarithromycin in two freshwater microalgae Raphidocelis subcapitata and Chlorella vulgaris.
Topics: Antioxidants; Catalase; Chlorella vulgaris; Chlorophyll A; Clarithromycin; Ecosystem; Fresh Water; Glutathione; Lipid Peroxidation; Malondialdehyde; Microalgae; Oxidative Stress; Photosynthesis; Superoxide Dismutase; Water Pollutants, Chemical | 2020 |